header
Local cover image
Local cover image
Image from OpenLibrary

A comparative randomized study of safety and efficacy of once versus twice daily dose of amikacin in treatment of neonatal sepsis / Aya Zeiada Mohamed ; Supervised Heba Hany Abu Hussein , Dalia Ahmed Khairy , Rania Ahmed Zayed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Aya Zeiada Mohamed , 2014Description: 97 P. ; 25cmOther title:
  • دراسة مقارنة عشوائية لمدى فاعلية و أمان عقار الأميكيسين كجرعة واحدة أو مزدوجة فى علاج التسمم البكتيرى لدى حديثى الولادة [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics Summary: Neonates frequently receive amikacin as empiric therapy for severe infections caused by suspected Gram - negative bacteria. Optimum dosing of amikacin is required because of the inter - individual variability in the pharmacokinetics in the neonatal population. This study was conducted to compare the efficacy and safety (nephrotoxicity) of once daily versus twice daily dosing of amikacin in suspected or proven sepsis in neonates in relation to the pharmacokinetics of the drug as well as amikacin pharmacokinetic parameters determination under these two dosing schedules in the septic neonates of the Egyptian population
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2014.Ay.C (Browse shelf(Opens below)) Not for loan 01010110063771000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.28.M.Sc.2014.Ay.C (Browse shelf(Opens below)) 63771.CD Not for loan 01020110063771000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics

Neonates frequently receive amikacin as empiric therapy for severe infections caused by suspected Gram - negative bacteria. Optimum dosing of amikacin is required because of the inter - individual variability in the pharmacokinetics in the neonatal population. This study was conducted to compare the efficacy and safety (nephrotoxicity) of once daily versus twice daily dosing of amikacin in suspected or proven sepsis in neonates in relation to the pharmacokinetics of the drug as well as amikacin pharmacokinetic parameters determination under these two dosing schedules in the septic neonates of the Egyptian population

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image